MCID: MYP004
MIFTS: 65

Myopathy

Categories: Bone diseases, Muscle diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Myopathy

Summaries for Myopathy

NINDS : 55 The myopathies are neuromuscular disorders in which the primary symptom is muscle weakness due to dysfunction of muscle fiber. Other symptoms of myopathy can include include muscle cramps, stiffness, and spasm. Myopathies can be inherited (such as the muscular dystrophies) or acquired (such as common muscle cramps). Myopathies are grouped as follows:congenital myopathies: characterized by developmental delays in motor skills; skeletal and facial abnormalities are occasionally evident at birthmuscular dystrophies: characterized by progressive weakness in voluntary muscles; sometimes evident at birthmitochondrial myopathies: caused by genetic abnormalities in mitochondria, cellular structures that control energy; include Kearns-Sayre syndrome, MELAS and MERRFglycogen storage diseases of muscle: caused by mutations in genes controlling enzymes that metabolize glycogen and glucose (blood sugar); include Pompe's, Andersen's and Cori's diseasesmyoglobinurias: caused by disorders in the metabolism of a fuel (myoglobin) necessary for muscle work; include McArdle, Tarui, and DiMauro diseasesdermatomyositis: an inflammatory myopathy of skin and musclemyositis ossificans: characterized by bone growing in muscle tissuefamilial periodic paralysis: characterized by episodes of weakness in the arms and legspolymyositis, inclusion body myositis, and related myopathies: inflammatory myopathies of skeletal muscleneuromyotonia: characterized by alternating episodes of twitching and stiffness; andstiff-man syndrome:  characterized by episodes of rigidity and reflex spasmscommon muscle cramps and stiffness, andtetany:  characterized by prolonged spasms of the arms and legs

MalaCards based summary : Myopathy, also known as muscular diseases, is related to nemaline myopathy and myopathy, distal, 1, and has symptoms including muscle weakness, myoclonus and back pain. An important gene associated with Myopathy is NEB (Nebulin), and among its related pathways/superpathways are Integrin Pathway and Cardiac conduction. The drugs Benzocaine and Entecavir have been mentioned in the context of this disorder. Affiliated tissues include skeletal muscle, testes and brain, and related phenotypes are no effect and behavior/neurological

Disease Ontology : 12 A muscular disease in which the muscle fibers do not function resulting in muscular weakness.

Wikipedia : 77 Myopathy is a disease of the muscle in which the muscle fibers do not function properly. This results in... more...

Related Diseases for Myopathy

Diseases in the Myopathy family:

Myopathy Due to Malate-Aspartate Shuttle Defect Myopathy, Congenital
Gne-Related Myopathy Benign Autosomal Dominant Myopathy

Diseases related to Myopathy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 1003)
# Related Disease Score Top Affiliating Genes
1 nemaline myopathy 34.3 ACTA1 CFL2 NEB TNNT1 TPM2
2 myopathy, distal, 1 34.2 CFL2 MYH2 MYH7
3 myopathy, proximal, and ophthalmoplegia 34.2 COL6A1 COL6A2 MYH2 RYR1
4 cap myopathy 34.2 ACTA1 TPM2
5 childhood-onset nemaline myopathy 34.1 ACTA1 NEB TPM2
6 severe congenital nemaline myopathy 34.1 ACTA1 NEB
7 reducing body myopathy 34.1 DES NEB
8 intermediate congenital nemaline myopathy 34.0 ACTA1 NEB
9 collagen vi-related myopathy 34.0 COL6A1 COL6A2 COL6A3
10 bethlem myopathy 1 34.0 COL6A1 COL6A2 COL6A3 DYSF SELENON
11 myofibrillar myopathy 33.9 ACTA1 CRYAB DES LDB3 NEB
12 myopathy, myofibrillar, 1 33.9 CRYAB DES LDB3 SELENON
13 myopathy, myofibrillar, 2 33.8 ACTA1 CRYAB LDB3 MYH7
14 inclusion body myositis 33.8 GNE MYH2 VCP
15 myopathy, spheroid body 33.8 CRYAB DES LDB3 MYH7 VCP
16 typical congenital nemaline myopathy 33.8 ACTA1 CFL2 NEB TPM2
17 myopathy, congenital, with fiber-type disproportion 33.8 ACTA1 MYH7 RYR1 SELENON
18 myopathy, myofibrillar, 4 33.7 AMPD1 LDB3
19 myopathy, congenital 33.6 ACTA1 DYSF MTM1 MYH7 NEB RYR1
20 central core myopathy 33.6 MTM1 MYH7 RYR1 SELENON
21 inclusion body myopathy with paget disease of bone and frontotemporal dementia 33.5 GNE VCP
22 central core disease of muscle 33.5 DES NEB RYR1 SELENON
23 rigid spine muscular dystrophy 1 33.4 ACTA1 COL6A2 DYSF MYH7 RYR1 SELENON
24 miyoshi muscular dystrophy 33.4 DYSF GNE MYH2 MYH7
25 ullrich congenital muscular dystrophy 1 33.3 COL6A1 COL6A2 COL6A3
26 congenital fiber-type disproportion 33.1 ACTA1 CFL2 DYSF MYH7 RYR1 SELENON
27 multiminicore disease 33.0 RYR1 SELENON
28 congenital structural myopathy 32.7 ACTA1 CFL2 NEB RYR1 SELENON TNNT1
29 muscle disorders 32.7 COL6A1 COL6A2 COL6A3 RYR1 SELENON
30 muscular dystrophy 31.6 ACTA1 COL6A1 COL6A2 COL6A3 DES DYSF
31 muscular dystrophy, congenital, lmna-related 31.3 COL6A1 COL6A2 COL6A3 MYH2 SELENON
32 muscular disease 31.1 ACTA1 COL6A1 COL6A2 COL6A3 DYSF GNE
33 hypertrophic cardiomyopathy 30.8 DES LDB3 MYH7 TNNT1
34 dilated cardiomyopathy 30.5 CRYAB DES LDB3 MYH7 TNNT1
35 restrictive cardiomyopathy 30.4 ACTA1 CRYAB DES MYH7 TNNT1
36 left ventricular noncompaction 30.3 DES LDB3 MYH7
37 arrhythmogenic right ventricular cardiomyopathy 30.2 DES LDB3 MYH7 RYR1
38 neuromuscular disease 30.1 AMPD1 DES GNE MTM1 RYR1
39 foot drop 30.0 ACTA1 NEB
40 nemaline myopathy 3 12.6
41 nemaline myopathy 5 12.5
42 myopathy, tubular aggregate, 1 12.5
43 myopathy, centronuclear, x-linked 12.5
44 centronuclear myopathy 12.5
45 myopathy, centronuclear, 1 12.5
46 myopathy, congenital, bailey-bloch 12.5
47 nonaka myopathy 12.5
48 myopathy, centronuclear, 2 12.4
49 myopathy, lactic acidosis, and sideroblastic anemia 1 12.4
50 myosin storage myopathy 12.4

Comorbidity relations with Myopathy via Phenotypic Disease Network (PDN):


Acute Cystitis Bronchitis
Deficiency Anemia Heart Disease
Hypertension, Essential Hypothyroidism
Respiratory Failure

Graphical network of the top 20 diseases related to Myopathy:



Diseases related to Myopathy

Symptoms & Phenotypes for Myopathy

UMLS symptoms related to Myopathy:


muscle weakness, myoclonus, back pain, myalgia, torticollis, sciatica, muscle cramp, joint symptom, muscle rigidity, muscle spasticity, spasmodic torticollis, musculoskeletal symptom, leg cramps

GenomeRNAi Phenotypes related to Myopathy according to GeneCards Suite gene sharing:

27
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 no effect GR00402-S-1 9.92 ACTA1 AMPD1 CFL2 COL6A1 COL6A2 COL6A3

MGI Mouse Phenotypes related to Myopathy:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.97 ACTA1 CFL2 COL6A2 CRYAB DES DYSF
2 growth/size/body region MP:0005378 9.7 ACTA1 CFL2 COL6A2 COL6A3 GNE LDB3
3 muscle MP:0005369 9.55 ACTA1 AMPD1 CFL2 COL6A1 COL6A3 CRYAB

Drugs & Therapeutics for Myopathy

Drugs for Myopathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 817)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 94-09-7, 1994-09-7 2337
2
Entecavir Approved, Investigational Phase 4 142217-69-4 153941
3
tannic acid Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1401-55-4
4
Telbivudine Approved, Investigational Phase 4 3424-98-4 159269
5
Pirfenidone Approved, Investigational Phase 4,Phase 3 53179-13-8 40632
6
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 302-25-0
7
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 50-24-8 5755
8
Methylprednisolone hemisuccinate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 2921-57-5
9
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 83-43-2 6741
10
Ethanol Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 64-17-5 702
11
Naltrexone Approved, Investigational, Vet_approved Phase 4,Phase 2,Not Applicable 16590-41-3 5360515
12
Milnacipran Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 92623-85-3 65833
13
Norepinephrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-41-2 439260
14
Levomilnacipran Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 96847-54-0
15
Etoricoxib Approved, Investigational Phase 4,Phase 3,Phase 1 202409-33-4 123619
16
Ramipril Approved Phase 4 87333-19-5 5362129
17
Carvedilol Approved, Investigational Phase 4 72956-09-3 2585
18
Amitriptyline Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-48-6 2160
19
Cyclobenzaprine Approved Phase 4,Phase 3,Phase 2,Not Applicable 303-53-7 2895
20
Perphenazine Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 58-39-9 4748
21
Gabapentin Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 60142-96-3 3446
22
Acetylcholine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-84-3 187
23
Lidocaine Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable,Early Phase 1 137-58-6 3676
24
Triamcinolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 124-94-7 31307
25
Sodium oxybate Approved Phase 4,Phase 3,Phase 2 502-85-2 5360545
26
Dinoprostone Approved Phase 4,Not Applicable 363-24-6 5280360
27
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 53-03-2 5865
28
Bezafibrate Approved, Investigational Phase 4,Phase 3,Phase 2 41859-67-0 39042
29
Atorvastatin Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 134523-00-5 60823
30
Simvastatin Approved Phase 4,Phase 3,Phase 2,Not Applicable 79902-63-9 54454
31
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-02-2 5743
32
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1177-87-3
33
Polidocanol Approved Phase 4,Phase 2 9002-92-0
34
Acetaminophen Approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 103-90-2 1983
35
Pregabalin Approved, Illicit, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 148553-50-8 5486971
36
Dopamine Approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 62-31-7, 51-61-6 681
37
Tramadol Approved, Investigational Phase 4,Phase 3,Phase 2 27203-92-5 33741
38
Tadalafil Approved, Investigational Phase 4,Phase 3,Phase 1,Early Phase 1,Not Applicable 171596-29-5 110635
39
Ibuprofen Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 15687-27-1 3672
40
Propranolol Approved, Investigational Phase 4,Phase 2,Phase 1,Not Applicable 525-66-6 4946
41
Propofol Approved, Investigational, Vet_approved Phase 4,Not Applicable 2078-54-8 4943
42
Baclofen Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1134-47-0 2284
43
Azathioprine Approved Phase 4,Phase 3,Not Applicable 446-86-6 2265
44
Colchicine Approved Phase 4,Phase 3,Not Applicable 64-86-8 6167 2833
45
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1,Not Applicable 9004-61-9 53477741
46
Betamethasone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 378-44-9 9782
47
Dronabinol Approved, Illicit Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1972-08-3 16078
48
Doxycycline Approved, Investigational, Vet_approved Phase 4,Not Applicable 564-25-0 54671203
49
Citalopram Approved Phase 4,Phase 3,Not Applicable 59729-33-8 2771
50
Abatacept Approved Phase 4,Phase 3,Phase 2,Early Phase 1 332348-12-6 10237

Interventional clinical trials:

(show top 50) (show all 3168)
# Name Status NCT ID Phase Drugs
1 Identification of Carnitine-Responsive Cardiomyopathy Unknown status NCT01904396 Phase 4 Carnitine
2 Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With Entecavir Unknown status NCT01588912 Phase 4 Telbivudine;Tenofovir;Entecavir
3 Muscular Electrostimulation of the Sedated and Mechanically Ventilated Critically Ill Patient. Analysis of the Effect on Acquired Muscular Weakness and Its Clinical Consequences. Unknown status NCT02033057 Phase 4
4 Pirfenidone in Progressive Interstitial Lung Disease Associated With Clinically Amyopathic Dermatomyositis Unknown status NCT02821689 Phase 4 Pirfenidone
5 6-Methyl-Prednisolone for Multiple Organ Dysfunction Syndrome Unknown status NCT00127985 Phase 4 6-methyl-prednisolone
6 A Randomized Trial to Evaluate the Effectiveness of Transferring the Flexor Hallucis Longus Tendon Unknown status NCT01341509 Phase 4
7 Low Dose Naltrexone for Treatment of Pain in Patients With Fibromyalgia - Effect Via a Central Mechanism? Unknown status NCT02806440 Phase 4 Low dose naltrexone;Placebo
8 Study of Fibromyalgia Treated With Milnacipran Unknown status NCT01125423 Phase 4 Milnacipran
9 Study Assessing the Efficacy of Etoricoxib in Female Patients With Fibromyalgia Unknown status NCT00755521 Phase 4 etoricoxib
10 The Study of Using Esophageal Pressure to Guide the PEEP Setting in Abdominal Hypertension Patients Who Undergoing Mechanical Ventilation Unknown status NCT01825304 Phase 4
11 Ramipril Versus Carvedilol in Duchenne and Becker Patients Unknown status NCT00819845 Phase 4 carvedilol;ramipril
12 The Preventive Efficacy of Carvedilol on Cardiac Dysfunction in Duchenne Muscular Dystrophy Unknown status NCT00606775 Phase 4 Carvedilol
13 Cyclobenzaprine Extended Release (ER) for Fibromyalgia Unknown status NCT01041495 Phase 4 cyclobenzaprine ER (AMRIX);placebo
14 Prospective, Cross Over Gabapentin vs Amitriptyline Study on Patients Suffering From Masticatory Muscle Pain Unknown status NCT02339662 Phase 4 Gabapentin;Amitriptyline
15 Upper Extremity Rehabilitation Using Robot and Botulinum Toxin Unknown status NCT02228863 Phase 4
16 Corticosteroid Injection Verses High Energy Extracorporeal Shock Wave Therapy for Lateral Epicondylitis Unknown status NCT02613455 Phase 4 Kenalog (triamcinolone);lidocaine 1% (lidocaine HCl 20mg)
17 The Effectiveness of Early Botulinum Toxin A Injection for Lower Limbs Spasticity in Subacute Stroke Adults Unknown status NCT02505802 Phase 4 BoNT-A injection
18 Effects of Functional Electrical Stimulation on Gait in Children With Cerebral Palsy Unknown status NCT02462018 Phase 4
19 Sodium Oxybate in Patients With Chronic Fatigue Syndrome. Unknown status NCT01584934 Phase 4 Sodium oxybate;Placebo
20 Evaluation of the Effects of L-Carnitine Injection in Patients Undergoing Hemodialysis Unknown status NCT00173706 Phase 4 L-Carnitine Injection
21 Rectus Femoris Tenotomy Versus Botulinum Toxin A for Stiff Knee Gait After Stroke Unknown status NCT02114736 Phase 4 Botulinum Toxin injection in the rectus femoris muscle
22 Antispastic Effect of Transcranial Magnetic Stimulation in Patients With Cerebral and Spinal Spasticity Unknown status NCT01786005 Phase 4
23 The Immune and Clinical Impacts of Vitamin D in Patients With Chronic Musculo-skeletal Pain Unknown status NCT01417923 Phase 4 vitamin D
24 Steroids Pharmacokinetics and the Response to Prednisone Therapy in Giant Cell Arteritis Unknown status NCT01400464 Phase 4 Prednisone therapy and pharmacokinetic
25 Nasal Continuous Positive Airway Pressure (CPAP) in Chronic Fatigue and Sleep-disordered Breathing Unknown status NCT01368718 Phase 4
26 Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases Unknown status NCT01151644 Phase 4
27 The Effect of Fibrate Therapy in Two Patients With Neutral Lipid Storage Disease With Myopathy (NLSDM) Completed NCT01527318 Phase 4 Fibrate treatment
28 Association Between Systemic Exposure of Atorvastatin and Metabolites and Atorvastatin-induced Myotoxicity Completed NCT00120055 Phase 4 Atorvastatin (Lipitor)
29 Investigations on Differences in Atorvastatin Metabolites Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity Completed NCT00414531 Phase 4 Atorvastatin
30 Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity Completed NCT00199745 Phase 4 atorvastatin
31 Using Clonidine to Improve Leg Weakness in People With Heart Failure Completed NCT00858845 Phase 4 Clonidine Patch
32 Two Different Dosages of Nebulized Steroid Versus Parenteral Steroid in the Management of COPD Exacerbations Completed NCT01865500 Phase 4 Budesonide 4 mg;Budesonide 8 mg;Metil prednisolone
33 Effects of Vitamin D Supplementation in Obesity Completed NCT01037140 Phase 4 Cholecalciferol;placebo
34 Effect of Gemfibrozil on the Safety and Pharmacokinetics of Red Yeast Rice in Healthy Subjects Completed NCT01385020 Phase 4 Gemfibrozil & red yeast rice (LipoCol)
35 Early Goal-Directed Nutrition in ICU Patients - EAT-ICU Trial Completed NCT01372176 Phase 4
36 Assessing the Role of "Statin" Therapy and Perioperative Inflammatory Response in Patients Undergoing Major Orthopedic Surgery Completed NCT00656292 Phase 4 Simvastatin;Placebo
37 Relation Between Intrabdominal Pressure and Collapsibility Index of Inferior Vena Cava Before and After Fluid Therapy Completed NCT01553422 Phase 4
38 Shockwave Therapy of Chronic Achilles Tendinopathy Completed NCT00958620 Phase 4
39 Long Term Effectiveness of Trigger Finger Injections With Triamcinolone vs. Dexamethasone Completed NCT03641508 Phase 4 Triamcinolone;Dexamethasone
40 "NSAIDs in Acute Achilles Tendinopathy: Effect on Pain Control, Leg Stiffness and Functional Recovery in Athletes" Completed NCT00792376 Phase 4 etoricoxib;diclofenac
41 The Value of Platelet-Rich Plasma in Chronic Midportion Achilles Tendinopathy: a Double-blind Randomized Clinical Trial Completed NCT00761423 Phase 4
42 Achilles Tendinosis Study; Comparison of Radiofrequency to Surgical MicroDebridement Completed NCT00534781 Phase 4
43 The Efficacy of Polidocanol Injections as a Treatment of Chronic Achilles. Tendinopathy Completed NCT00377910 Phase 4 Aethoxysclerol
44 Colloids in Severe Trauma Completed NCT00890383 Phase 4 tetrastarch (Voluven)
45 Comparison of Efficacy of Intravenous Paracetamol and Dexketoprofen for Acute Traumatic Musculoskeletal Pain Completed NCT03428503 Phase 4 Paracetamol;Dexketoprofen
46 Comparison of Efficacy of Intravenous Paracetamol and Dexketoprofen for Acute Nontraumatic Musculoskeletal Pain Completed NCT03122314 Phase 4 Paracetamol;Dexketoprofen
47 Discomfort and Psychosocial Difficulties in Fibromyalgia Completed NCT02078791 Phase 4 Botox infiltration
48 Strengthening Exercises for Fibromyalgia Completed NCT02063750 Phase 4
49 Heart Rate Variability in Fibromyalgia - Effects of Strengthening Exercises Completed NCT02004405 Phase 4
50 Responses to Influenza Vaccine in Patients With Mitochondrial Disorders (MELAS) Completed NCT01831934 Phase 4

Search NIH Clinical Center for Myopathy

Cochrane evidence based reviews: muscular diseases

Genetic Tests for Myopathy

Anatomical Context for Myopathy

MalaCards organs/tissues related to Myopathy:

42
Skeletal Muscle, Testes, Brain, Bone, Heart, Spinal Cord, Lung

Publications for Myopathy

Articles related to Myopathy:

(show top 50) (show all 5238)
# Title Authors Year
1
Telbivudine-Induced Myopathy Incidentally Detected by FDG PET/CT Imaging in a Patient With History of Hepatocellular Carcinoma. ( 30608913 )
2019
2
Centronuclear myopathy with cardiomyopathy due to recessive titinopathy. ( 30681174 )
2019
3
Nuclear defects in skeletal muscle from a Dynamin 2-linked centronuclear myopathy mouse model. ( 30733559 )
2019
4
Homozygous variant in OTX2 and possible genetic modifiers identified in a patient with combined pituitary hormone deficiency, ocular involvement, myopathy, ataxia, and mitochondrial impairment. ( 30773800 )
2019
5
Dilated cardiomyopathy-mediated heart failure induces a unique skeletal muscle myopathy with inflammation. ( 30678732 )
2019
6
Emery-Dreifuss muscular dystrophy-related myopathy with TMEM43 mutations. ( 30311943 )
2019
7
Broadening the phenotype of m.5703G>A mutation in mitochondrial tRNAAsn gene from mitochondrial myopathy to myoclonic epilepsy with ragged red fibers syndrome. ( 30897601 )
2019
8
Toxic myopathy with multiple deletions in mitochondrial DNA associated with long-term use of oral anti-viral drugs for hepatitis B: A case study. ( 30847961 )
2019
9
The Importance of Patient Input into Development of Outcomes in Idiopathic Inflammatory Myopathy. ( 30600235 )
2019
10
Efficacy and safety of rituximab in anti-synthetase antibody positive and negative subjects with idiopathic inflammatory myopathy: a registry-based study. ( 30690633 )
2019
11
Venous Thromboembolic Events in Idiopathic Inflammatory Myopathy: Occurrence and Relation to Disease Onset: comment on the article by Antovic et al. ( 30762946 )
2019
12
Comparison of MR T1 and T2 mapping parameters to characterize myocardial and skeletal muscle involvement in systemic idiopathic inflammatory myopathy (IIM). ( 30847587 )
2019
13
Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy. ( 30588482 )
2019
14
Clinical findings and autophagic pathology in neutral lipid storage disease with myopathy. ( 30738494 )
2019
15
Mitochondrial complex IV deficiency caused by a novel frameshift variant in MT-CO2 associated with myopathy and perturbed acylcarnitine profile. ( 30315213 )
2019
16
Mitochondrial myopathy associated with anti-programmed cell death 1 therapy. ( 30772655 )
2019
17
Late Onset Multiple Acyl-CoA Dehydrogenase Deficiency (MADD) Myopathy Misdiagnosed as Polymyositis. ( 30801335 )
2019
18
Severe Neonatal RYR1 Myopathy With Pathological Features of Congenital Muscular Dystrophy. ( 30715496 )
2019
19
Congenital myopathy with a novel SELN missense mutation and the challenge to differentiate it from congenital muscular dystrophy. ( 30612914 )
2019
20
PD-1 inhibitor-associated severe myasthenia gravis with necrotizing myopathy and myocarditis. ( 30798111 )
2019
21
Inflammatory myopathy with myasthenia gravis: Thymoma association and polymyositis pathology. ( 30697585 )
2019
22
Pembrolizumab-induced Ocular Myasthenia Gravis with Anti-titin Antibody and Necrotizing Myopathy. ( 30713313 )
2019
23
A novel mutation in the N-terminal acting-binding domain of Filamin C protein causing a distal myofibrillar myopathy. ( 30685713 )
2019
24
Motor unit potential changes in myofibrillar myopathy. ( 30913523 )
2019
25
A Female Patient with Xq28 Microduplication Presenting with Myotubular Myopathy, Confirmed with a Custom-Designed X-array. ( 30541163 )
2019
26
Autophagic vacuolar myopathy caused by a CLN3 mutation. A case report. ( 30553701 )
2019
27
Late onset distal myopathy: A new telethoninopathy. ( 30553702 )
2019
28
Tacrolimus combined with corticosteroids effectively improved the outcome of a cohort of patients with immune-mediated necrotising myopathy. ( 30620290 )
2019
29
Atypical myopathy-associated hypoglycin A toxin remains in sycamore seedlings despite mowing, herbicidal spraying or storage in hay and silage. ( 30629759 )
2019
30
Tiger man sign in sarcoid myopathy. ( 30637499 )
2019
31
Review: Myositis-specific autoantibodies, a cornerstone in immune-mediated necrotizing myopathy. ( 30639649 )
2019
32
Long-term follow-up and characteristic pathological findings in severe nemaline myopathy due to LMOD3 mutations. ( 30642739 )
2019
33
Acute Proximal Myopathy in a Young Male-A Case of Infectious Myositis. ( 30658484 )
2019
34
18F-FDG PET/CT versus conventional investigations for cancer screening in autoimmune inflammatory myopathy in the era of novel myopathy classifications. ( 30664602 )
2019
35
Whole-exome sequencing identifies rare compound heterozygous mutations in the MSTO1 gene associated with cerebellar ataxia and myopathy. ( 30684668 )
2019
36
Deleting nebulin's C-terminus reveals its importance to sarcomeric structure and function and is sufficient to invoke nemaline myopathy. ( 30689900 )
2019
37
The effects of an alternative diet regimen with natural methionine ingredients on white striping breast myopathy in broiler chickens. ( 30690615 )
2019
38
Neuromuscular Ultrasound as an Initial Evaluation for Suspected Myopathy: A Case Report. ( 30697769 )
2019
39
Bethlem myopathy: a series of 16 patients and description of seven new associated mutations. ( 30706156 )
2019
40
A case of simvastatin-induced myopathy with SLCO1B1 genetic predisposition and co-ingestion of linagliptin and Stevia rebaudiana. ( 30714173 )
2019
41
Detection of MCPG metabolites in horses with atypical myopathy. ( 30721263 )
2019
42
Pearls & Oy-sters: Hydroxychloroquine-induced toxic myopathy mimics Pompe disease: Critical role of genetic test. ( 30745451 )
2019
43
Declaration of the known facts in myopathy: Pacing in order to capture future occurrence of PVC-induced myopathy? ( 30758049 )
2019
44
Editorial for "Declaration of the known facts in myopathy: Pacing in order to capture future occurrence of PVC-induced myopathy?" ( 30758068 )
2019
45
Stormorken Syndrome: A Rare Cause of Myopathy With Tubular Aggregates and Dystrophic Features. ( 30761937 )
2019
46
Congenital myopathy-related mutations in tropomyosin disrupt regulatory function through altered actin affinity and tropomodulin binding. ( 30768849 )
2019
47
Recessive mutations in muscle-specific isoforms of FXR1 cause congenital multi-minicore myopathy. ( 30770808 )
2019
48
Proprotein Convertase Subtilisin/Kexin Type 9 Antibody and Statin-Associated Autoimmune Myopathy. ( 30776798 )
2019
49
Comments on: Isolated Nonocompaction Suggests Subclinical Myopathy. ( 30786312 )
2019
50
Anti-HMG-CoA reductase myopathy, an undesirable evolution of statin induced myopathy: a case report. ( 30788073 )
2019